OTC Markets OTCPK - Delayed Quote USD

Revenio Group Oyj (REVXF)

Compare
27.85
0.00
(0.00%)
At close: April 3 at 4:00:00 PM EDT
Loading Chart for REVXF
  • Previous Close 38.89
  • Open 38.89
  • Bid 23.01 x 34100
  • Ask 28.01 x 1300
  • Day's Range 38.89 - 38.89
  • 52 Week Range 27.85 - 38.89
  • Volume 100
  • Avg. Volume 0
  • Market Cap (intraday) 746.419M
  • Beta (5Y Monthly) 1.48
  • PE Ratio (TTM) 36.64
  • EPS (TTM) 0.76
  • Earnings Date Apr 29, 2025
  • Forward Dividend & Yield 0.40 (1.45%)
  • Ex-Dividend Date Apr 11, 2025
  • 1y Target Est --

Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, rest of Europe, North America, and internationally. The company offers iCare IC100 and IC200 tonometers; iCare HOME, a device for self-measurement of eye pressure; and iCare TONOVET an IOP measuring on animal patients by general veterinary practitioners, veterinary ophthalmologists, and other veterinary medical personnel. It also provides imaging devices comprising iCare EIDON AF, a device with confocal retinal imaging; and DRSplus, a device for pupil imaging; and iCare COMPASS, which provides fundus perimetry with true-color confocal retinal images. In addition, the company offers Oculo, an eye care software platform, which combines clinical communication, telehealth, remote patient monitoring and data analytics capabilities. Revenio Group Oyj was incorporated in 2001 and is based in Vantaa, Finland.

www.reveniogroup.fi

241

Full Time Employees

December 31

Fiscal Year Ends

Recent News: REVXF

View More

Performance Overview: REVXF

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is OMX Helsinki_PI (^OMXHPI) .

YTD Return

REVXF
0.00%
OMX Helsinki_PI (^OMXHPI)
0.00%

1-Year Return

REVXF
0.43%
OMX Helsinki_PI (^OMXHPI)
0.00%

3-Year Return

REVXF
62.13%
OMX Helsinki_PI (^OMXHPI)
0.00%

5-Year Return

REVXF
4,894.05%
OMX Helsinki_PI (^OMXHPI)
0.00%

Compare To: REVXF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: REVXF

View More

Valuation Measures

Annual
As of 4/3/2025
  • Market Cap

    704.79M

  • Enterprise Value

    696.17M

  • Trailing P/E

    36.79

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    6.57

  • Price/Book (mrq)

    6.30

  • Enterprise Value/Revenue

    6.52

  • Enterprise Value/EBITDA

    22.12

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    17.82%

  • Return on Assets (ttm)

    11.42%

  • Return on Equity (ttm)

    17.82%

  • Revenue (ttm)

    103.82M

  • Net Income Avi to Common (ttm)

    18.5M

  • Diluted EPS (ttm)

    0.76

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    20.69M

  • Total Debt/Equity (mrq)

    11.87%

  • Levered Free Cash Flow (ttm)

    17.53M

Research Analysis: REVXF

View More

Company Insights: REVXF

Research Reports: REVXF

View More

People Also Watch